{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT01652092",
            "orgStudyIdInfo": {
                "id": "2012OC055"
            },
            "secondaryIdInfos": [
                {
                    "id": "MT2012-10C",
                    "type": "OTHER",
                    "domain": "Blood and Marrow Transplantation Program"
                }
            ],
            "organization": {
                "fullName": "Masonic Cancer Center, University of Minnesota",
                "class": "OTHER"
            },
            "briefTitle": "Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies",
            "officialTitle": "Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies",
            "therapeuticArea": [
                "Critical Care",
                "Rare Diseases",
                "Other"
            ],
            "study": "allogeneic-hematopoietic-stem-cell-transplant-for-patients-with-primary-immune-deficiencies"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2012-09-04",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2012-07-25",
            "studyFirstSubmitQcDate": "2012-07-26",
            "studyFirstPostDateStruct": {
                "date": "2012-07-27",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2024-01-25",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-26",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Masonic Cancer Center, University of Minnesota",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true
        },
        "descriptionModule": {
            "briefSummary": "This is a standard of care treatment guideline for allogeneic hematopoetic stem cell transplant (HSCT) in patients with primary immune deficiencies.",
            "detailedDescription": "Based on diagnosis and clinical history, a determination of the most appropriate regimen will be made based on the following prep plans:\n\nArm A: Fully Myeloablative Preparative Regimen, Arm B: Reduced Toxicity Ablative Preparative Regimen, Arm C: Reduced Intensity Conditioning, Arm D: No Preparative Regimen"
        },
        "conditionsModule": {
            "conditions": [
                "SCID",
                "Omenn's Syndrome",
                "Reticular Dysgenesis",
                "Wiskott-Aldrich Syndrome",
                "Bare Lymphocyte Syndrome",
                "Common Variable Immunodeficiency",
                "Chronic Granulomatous Disease",
                "CD40 Ligand Deficiency",
                "Hyper IgM Syndrome",
                "X-linked Lymphoproliferative Disease",
                "Hemophagocytic Lymphohistiocytosis",
                "Griscelli Syndrome",
                "Chediak-Higashi Syndrome",
                "Langerhan's Cell Histiocytosis"
            ],
            "keywords": [
                "immunodeficiency disorder",
                "histiocytic disorder"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Arm A: Fully Myeloablative regimen",
                    "type": "OTHER",
                    "description": "For use in patients with diseases including Wiskott-Aldrich syndrome, MHC Class II deficiency, hypomorphic SCID, etc. Receives Alemtuzumab 0.3 mg/kg intravenously (IV) on days -12 through -10, cyclophosphamide 50 mg/kg IV plus MESNA on days -9 through -6, busulfan 0.8 or 1.1 mg/kg IV on days -5 through -2 and stem cell infusion on day 0.",
                    "interventionNames": [
                        "Drug: Alemtuzumab 0.3 mg",
                        "Drug: Cyclophosphamide",
                        "Drug: Busulfan",
                        "Biological: Stem Cell Transplantation",
                        "Drug: MESNA"
                    ]
                },
                {
                    "label": "Arm B: Reduced Toxicity Ablative Regimen",
                    "type": "OTHER",
                    "description": "For use in patients with diseases including SCID, CGD, CHS and other CID. Receives Alemtuzumab 0.3 mg/kg intravenously (IV) on days -12 through -10, busulfan 0.8 or 1.1 mg/kg IV on days -9 through -6, fludarabine phosphate 40 mg/m\\^2 IV on days -5 through -2 and stem cell infusion on day 0.",
                    "interventionNames": [
                        "Drug: Alemtuzumab 0.3 mg",
                        "Biological: Stem Cell Transplantation",
                        "Drug: Fludarabine phosphate 40 mg",
                        "Drug: Busulfan"
                    ]
                },
                {
                    "label": "Arm C: Reduced Intensity Conditioning",
                    "type": "OTHER",
                    "description": "For use in patients with diseases including HLH. Receives Alemtuzumab 0.2 mg/kg intravenously (IV) on days -14 through -10, fludarabine phosphate 30 mg/m\\^2 IV on days -8 through -4, melphalan 140 mg/m\\^2 IV on day -3 and stem cell infusion on day 0.",
                    "interventionNames": [
                        "Biological: Stem Cell Transplantation",
                        "Drug: Melphalan",
                        "Drug: Alemtuzumab 0.2 mg",
                        "Drug: Fludarabine phosphate 30 mg"
                    ]
                },
                {
                    "label": "Arm D: No Preparative Regimen",
                    "type": "OTHER",
                    "description": "For use in patients with complete SCID phenotype with no evidence of maternal engraftment or residual immune function who will be receiving their stem cell transplantation from a genotypically matched donor.",
                    "interventionNames": [
                        "Biological: Stem Cell Transplantation"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Alemtuzumab 0.3 mg",
                    "description": "0.3 mg/kg intravenously (IV) on days -12 through -10",
                    "armGroupLabels": [
                        "Arm A: Fully Myeloablative regimen",
                        "Arm B: Reduced Toxicity Ablative Regimen"
                    ],
                    "otherNames": [
                        "Campath-1H"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Cyclophosphamide",
                    "description": "cyclophosphamide 50 mg/kg IV on days -9 through -6",
                    "armGroupLabels": [
                        "Arm A: Fully Myeloablative regimen"
                    ],
                    "otherNames": [
                        "Cytoxan"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Busulfan",
                    "description": "busulfan 0.8 or 1.1 mg/kg IV on days -5 through -2",
                    "armGroupLabels": [
                        "Arm A: Fully Myeloablative regimen"
                    ],
                    "otherNames": [
                        "Myerlan"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Stem Cell Transplantation",
                    "description": "Unrelated donor bone marrow will be collected in the usual manner using established parameters determined by the National Marrow Donor Program. A minimum of 3 x 10\\^8 nucleated cells/kg recipient weight will be collected with a goal of \u2265 5 x 10\\^8 nucleated cells/kg recipient weight.\n\nUmbilical cord blood selection will be per the current University of Minnesota Cord Blood Unit Selection algorithm. One or two units may be used to obtain the minimum cell dose. One of the UCB units selected for transplantation must contain \u2265 3.5 x 10\\^7 nucleated cells/kg recipient weight based on cell numbers at time of cryopreservation, and the total combined cell dose of both units must be \\> 5.0 x 10\\^7 nucleated cells/kg.",
                    "armGroupLabels": [
                        "Arm A: Fully Myeloablative regimen",
                        "Arm B: Reduced Toxicity Ablative Regimen",
                        "Arm C: Reduced Intensity Conditioning",
                        "Arm D: No Preparative Regimen"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Fludarabine phosphate 40 mg",
                    "description": "40 mg/m\\^2 IV on days -5 through -2 (for children \\< 6 months and/or \\< 10 kg weight dose at 1.33 mg/kg)",
                    "armGroupLabels": [
                        "Arm B: Reduced Toxicity Ablative Regimen"
                    ],
                    "otherNames": [
                        "Fludara"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Melphalan",
                    "description": "140 mg/m\\^2 IV on day -3",
                    "armGroupLabels": [
                        "Arm C: Reduced Intensity Conditioning"
                    ],
                    "otherNames": [
                        "Alkeran"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Alemtuzumab 0.2 mg",
                    "description": "0.2 mg/kg intravenously (IV) on days -14 through -10",
                    "armGroupLabels": [
                        "Arm C: Reduced Intensity Conditioning"
                    ],
                    "otherNames": [
                        "Campath 1-H"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Busulfan",
                    "description": "busulfan 0.8 or 1.1 mg/kg IV on days -9 through -6",
                    "armGroupLabels": [
                        "Arm B: Reduced Toxicity Ablative Regimen"
                    ],
                    "otherNames": [
                        "Myerlan"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Fludarabine phosphate 30 mg",
                    "description": "fludarabine 30 mg/m\\^2 IV on days -8 through -4",
                    "armGroupLabels": [
                        "Arm C: Reduced Intensity Conditioning"
                    ],
                    "otherNames": [
                        "Fludara"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "MESNA",
                    "description": "administered as per the standard institutional protocol.",
                    "armGroupLabels": [
                        "Arm A: Fully Myeloablative regimen"
                    ],
                    "otherNames": [
                        "mercaptoethane sulfonate Na (Na being the symbol for sodium)",
                        "Mesnex"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Neutrophil Engraftment",
                    "description": "Neutrophil engraftment is defined as the first day of three consecutive days where the neutrophil count (absolute neutrophil count) is 500 cells/mm3 (0.5 x 109/L) or greater.",
                    "timeFrame": "Day 42"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Incidence of Graft Failure",
                    "description": "Graft failure is defined as not accepting donated cells. The donated cells do not make the new white blood cells, red blood cells and platelets.",
                    "timeFrame": "Day 100"
                },
                {
                    "measure": "Incidence of Chimerism",
                    "description": "a state in bone marrow transplantation in which bone marrow and host cells exist compatibly without signs of graft-versus-host rejection disease.",
                    "timeFrame": "Day 100, 6 Months, 1 Year"
                },
                {
                    "measure": "Incidence of Acute Graft-Versus-Host Disease",
                    "description": "Acute Graft-Versus-Host Disease is a severe short-term complication created by infusion of donor cells into a foreign host.",
                    "timeFrame": "Day 100"
                },
                {
                    "measure": "Incidence of Chronic Graft-Versus-Host Disease",
                    "description": "Chronic Graft-Versus-Host Disease is a severe long-term complication created by infusion of donor cells into a foreign host.",
                    "timeFrame": "6 Months and 1 Year"
                },
                {
                    "measure": "Incidence of Transplant-Related Mortality",
                    "description": "In the field of transplantation, toxicity is high and all deaths without previous relapse or progression are usually considered as related to transplantation.",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Disease-Free Survival",
                    "description": "the length of time after treatment ends that a patient survives without any signs or symptoms of that cancer or any other type of cancer. In a clinical trial, measuring the disease-free survival is one way to see how well a new treatment works.",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Overall Survival",
                    "description": "Overall survival will be defined as time from enrollment to date of death or censored at the date of last documented contact for patients still alive.",
                    "timeFrame": "6 Months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of immunodeficiency or histiocytic disorder including the following:\n\n  * Severe combined immunodeficiency (SCID - all variants)\n  * Second bone marrow transplant (BMT) for SCID (after graft rejection)\n  * Omenn's Syndrome\n  * Reticular dysgenesis\n  * Wiskott-Aldrich syndrome\n  * Major histocompatibility complex (MHC) Class II deficiency (bare lymphocyte syndrome)\n  * Hyper IgM Syndrome (CD40 Ligand Deficiency)\n  * Common variable immunodeficiency (CVID) with severe phenotype\n  * Chronic Granulomatous Disease (CGD)\n  * Other severe Combined Immune Deficiencies (CID)\n  * Hemophagocytic Lymphohistiocytosis (HLH)\n  * X-linked Lymphoproliferative Disease (XLP)\n  * Chediak-Higashi Syndrome (CHS)\n  * Griscelli Syndrome\n  * Langerhans Cell Histiocytosis (LCH)\n* Acceptable stem cell sources include:\n\n  * HLA identical or 1 antigen matched sibling donor eligible to donate bone marrow\n  * HLA identical or up to a 1 antigen mismatched unrelated BM donor\n  * Sibling donor cord blood with acceptable HLA match and cell dose as per current institutional standards\n  * Single unrelated umbilical cord blood unit with 0-2 antigen mismatch and minimum cell dose of \\>5 x 10\\^7 nucleated cells/kg as per current institutional guidelines\n  * Double unrelated umbilical cord blood units that are:\n\n    * up to 2 antigen mismatched to the patient\n    * up to 2 antigen mismatched to each other\n    * minimum cell dose of at least one single unit must be \u2265 3.5 x 10\\^7 nucleated cells/kg\n    * combined dose of both units must provide a total cell dose of \u2265 5 x 10\\^7 nucleated cells/kg\n* Age: 0 to 50 years\n* Adequate organ function and performance status.\n\nExclusion Criteria\n\n* pregnant or breastfeeding\n* active, uncontrolled infection and/or HIV positive\n* acute hepatitis or evidence of moderate or severe portal fibrosis or cirrhosis on biopsy",
            "healthyVolunteers": false,
            "sex": "ALL",
            "maximumAge": "50 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Christen Ebens, MD",
                    "role": "CONTACT",
                    "phone": "612-626-2778",
                    "email": "ebens012@umn.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Christen Ebens, MD",
                    "affiliation": "Masonic Cancer Center, University of Minnesota",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Masonic Cancer Center, University of Minnesota",
                    "status": "RECRUITING",
                    "city": "Minneapolis",
                    "state": "Minnesota",
                    "zip": "55455",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Christen Ebens, MD",
                            "role": "CONTACT",
                            "phone": "612-626-2778",
                            "email": "ebens012@umn.edu"
                        },
                        {
                            "name": "Christen Ebens, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.97997,
                        "lon": -93.26384
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006646",
                    "term": "Histiocytosis, Langerhans-Cell"
                },
                {
                    "id": "D000002609",
                    "term": "Chediak-Higashi Syndrome"
                },
                {
                    "id": "D000015614",
                    "term": "Histiocytosis"
                },
                {
                    "id": "D000051359",
                    "term": "Lymphohistiocytosis, Hemophagocytic"
                },
                {
                    "id": "D000006105",
                    "term": "Granulomatous Disease, Chronic"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000014923",
                    "term": "Wiskott-Aldrich Syndrome"
                },
                {
                    "id": "D000053306",
                    "term": "Hyper-IgM Immunodeficiency Syndrome"
                },
                {
                    "id": "D000053307",
                    "term": "Hyper-IgM Immunodeficiency Syndrome, Type 1"
                },
                {
                    "id": "D000081207",
                    "term": "Primary Immunodeficiency Diseases"
                },
                {
                    "id": "D000016511",
                    "term": "Severe Combined Immunodeficiency"
                },
                {
                    "id": "D000007153",
                    "term": "Immunologic Deficiency Syndromes"
                },
                {
                    "id": "D000017074",
                    "term": "Common Variable Immunodeficiency"
                },
                {
                    "id": "D000013577",
                    "term": "Syndrome"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004194",
                    "term": "Disease"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000015616",
                    "term": "Histiocytosis, Non-Langerhans-Cell"
                },
                {
                    "id": "D000010585",
                    "term": "Phagocyte Bactericidal Dysfunction"
                },
                {
                    "id": "D000007960",
                    "term": "Leukocyte Disorders"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000040181",
                    "term": "Genetic Diseases, X-Linked"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000025861",
                    "term": "Blood Coagulation Disorders, Inherited"
                },
                {
                    "id": "D000001778",
                    "term": "Blood Coagulation Disorders"
                },
                {
                    "id": "D000008231",
                    "term": "Lymphopenia"
                },
                {
                    "id": "D000007970",
                    "term": "Leukopenia"
                },
                {
                    "id": "D000095542",
                    "term": "Cytopenia"
                },
                {
                    "id": "D000006474",
                    "term": "Hemorrhagic Disorders"
                },
                {
                    "id": "D000004406",
                    "term": "Dysgammaglobulinemia"
                },
                {
                    "id": "D000001796",
                    "term": "Blood Protein Disorders"
                },
                {
                    "id": "D000000417",
                    "term": "Albinism"
                },
                {
                    "id": "D000015785",
                    "term": "Eye Diseases, Hereditary"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                },
                {
                    "id": "D000007232",
                    "term": "Infant, Newborn, Diseases"
                },
                {
                    "id": "D000049914",
                    "term": "DNA Repair-Deficiency Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000017563",
                    "term": "Lung Diseases, Interstitial"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "asFound": "Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12",
                    "name": "Congenital Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M2285",
                    "name": "Primary Immunodeficiency Diseases",
                    "asFound": "Primary Immune Deficiency",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10199",
                    "name": "Immunologic Deficiency Syndromes",
                    "asFound": "Immunodeficiency",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "asFound": "X-linked Lymphoproliferative Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26695",
                    "name": "Lymphohistiocytosis, Hemophagocytic",
                    "asFound": "Hemophagocytic Lymphohistiocytosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19398",
                    "name": "Common Variable Immunodeficiency",
                    "asFound": "Common Variable Immunodeficiency",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9208",
                    "name": "Granulomatous Disease, Chronic",
                    "asFound": "Chronic Granulomatous Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9721",
                    "name": "Histiocytosis, Langerhans-Cell",
                    "asFound": "Langerhan's Cell Histiocytosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18216",
                    "name": "Histiocytosis",
                    "asFound": "Histiocytosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M27210",
                    "name": "Hyper-IgM Immunodeficiency Syndrome",
                    "asFound": "Hyper-IgM Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M27211",
                    "name": "Hyper-IgM Immunodeficiency Syndrome, Type 1",
                    "asFound": "Hyper-IgM Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5855",
                    "name": "Chediak-Higashi Syndrome",
                    "asFound": "Chediak-Higashi Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17662",
                    "name": "Wiskott-Aldrich Syndrome",
                    "asFound": "Wiskott-Aldrich Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18908",
                    "name": "Severe Combined Immunodeficiency",
                    "asFound": "Bare Lymphocyte Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M18218",
                    "name": "Histiocytosis, Non-Langerhans-Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M13493",
                    "name": "Phagocyte Bactericidal Dysfunction",
                    "relevance": "LOW"
                },
                {
                    "id": "M10963",
                    "name": "Leukocyte Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M24877",
                    "name": "Genetic Diseases, X-Linked",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M21977",
                    "name": "Hemostatic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5059",
                    "name": "Blood Coagulation Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M23095",
                    "name": "Blood Coagulation Disorders, Inherited",
                    "relevance": "LOW"
                },
                {
                    "id": "M11224",
                    "name": "Lymphopenia",
                    "relevance": "LOW"
                },
                {
                    "id": "M10973",
                    "name": "Leukopenia",
                    "relevance": "LOW"
                },
                {
                    "id": "M3170",
                    "name": "Cytopenia",
                    "relevance": "LOW"
                },
                {
                    "id": "M9560",
                    "name": "Hemorrhagic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5077",
                    "name": "Blood Protein Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M3764",
                    "name": "Albinism",
                    "relevance": "LOW"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M18339",
                    "name": "Eye Diseases, Hereditary",
                    "relevance": "LOW"
                },
                {
                    "id": "M10276",
                    "name": "Infant, Newborn, Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M26131",
                    "name": "DNA Repair-Deficiency Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M19813",
                    "name": "Lung Diseases, Interstitial",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "T1429",
                    "name": "Common Variable Immunodeficiency",
                    "asFound": "Common Variable Immunodeficiency",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1304",
                    "name": "Chronic Granulomatous Disease",
                    "asFound": "Chronic Granulomatous Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5990",
                    "name": "X-linked Lymphoproliferative Syndrome",
                    "asFound": "X-linked Lymphoproliferative Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3306",
                    "name": "Langerhans Cell Histiocytosis",
                    "asFound": "Langerhan's Cell Histiocytosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3022",
                    "name": "Immunodeficiency With Hyper IgM Type 1",
                    "asFound": "Hyper-IgM Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5939",
                    "name": "Wiskott Aldrich Syndrome",
                    "asFound": "Wiskott-Aldrich Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1123",
                    "name": "Chediak-Higashi Syndrome",
                    "asFound": "Chediak-Higashi Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2625",
                    "name": "Griscelli Syndrome",
                    "asFound": "Griscelli Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4239",
                    "name": "Omenn Syndrome",
                    "asFound": "Omenn Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4934",
                    "name": "Reticular Dysgenesis",
                    "asFound": "Reticular Dysgenesis",
                    "relevance": "HIGH"
                },
                {
                    "id": "T676",
                    "name": "Bare Lymphocyte Syndrome",
                    "asFound": "Bare Lymphocyte Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "T677",
                    "name": "Bare Lymphocyte Syndrome 2",
                    "asFound": "Bare Lymphocyte Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5187",
                    "name": "Severe Combined Immunodeficiency",
                    "relevance": "LOW"
                },
                {
                    "id": "T4155",
                    "name": "Non-Langerhans-Cell Histiocytosis",
                    "relevance": "LOW"
                },
                {
                    "id": "T263",
                    "name": "Albinism",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014740",
                    "term": "Vidarabine"
                },
                {
                    "id": "D000003520",
                    "term": "Cyclophosphamide"
                },
                {
                    "id": "D000008558",
                    "term": "Melphalan"
                },
                {
                    "id": "D000002066",
                    "term": "Busulfan"
                },
                {
                    "id": "C000024352",
                    "term": "Fludarabine"
                },
                {
                    "id": "C000042382",
                    "term": "Fludarabine phosphate"
                },
                {
                    "id": "D000074323",
                    "term": "Alemtuzumab"
                },
                {
                    "id": "D000015080",
                    "term": "Mesna"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                },
                {
                    "id": "D000018906",
                    "term": "Antineoplastic Agents, Alkylating"
                },
                {
                    "id": "D000000477",
                    "term": "Alkylating Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000019653",
                    "term": "Myeloablative Agonists"
                },
                {
                    "id": "D000000964",
                    "term": "Antimetabolites, Antineoplastic"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000000998",
                    "term": "Antiviral Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                },
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000020011",
                    "term": "Protective Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6727",
                    "name": "Cyclophosphamide",
                    "asFound": "Effect of",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11541",
                    "name": "Melphalan",
                    "asFound": "Controlled Study",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5336",
                    "name": "Busulfan",
                    "asFound": "Anesthetic",
                    "relevance": "HIGH"
                },
                {
                    "id": "M283230",
                    "name": "Fludarabine",
                    "asFound": "Rate",
                    "relevance": "HIGH"
                },
                {
                    "id": "M225513",
                    "name": "Fludarabine phosphate",
                    "asFound": "Personalized",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1347",
                    "name": "Alemtuzumab",
                    "asFound": "Transcranial Direct Current Stimulation",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17811",
                    "name": "Mesna",
                    "asFound": "Interpret",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17485",
                    "name": "Vidarabine",
                    "asFound": "Personalized",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20942",
                    "name": "Antineoplastic Agents, Alkylating",
                    "relevance": "LOW"
                },
                {
                    "id": "M3820",
                    "name": "Alkylating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M4314",
                    "name": "Antiviral Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M21869",
                    "name": "Protective Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                }
            ]
        }
    },
    "hasResults": false
}